ARBUTUS BIOPHARMA CORP shareholders Q3 2023

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

ARBUTUS BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
PRINCIPAL FINANCIAL GROUP INC 45,600$92,5680.00%
PRUDENTIAL FINANCIAL INC 11,365$23,0710.00%
QUADRANT CAPITAL GROUP LLC 912$1,8520.00%
TWO SIGMA INVESTMENTS, LP 25,312$51,3830.00%
FMR LLC 176,139$357,5620.00%
US BANCORP \DE\ 1,909$3,8750.00%
Parallel Advisors, LLC 550$1,1170.00%
BANK OF AMERICA CORP /DE/ 90,760$184,2430.00%
FIRST MANHATTAN CO. LLC. 14,000$28,4190.00%
Russell Investments Group, Ltd. 4,103$8,3290.00%
WELLS FARGO & COMPANY/MN 32,108$65,1790.00%
NORTHERN TRUST CORP 1,065,372$2,162,7050.00%
AMERICAN CENTURY COMPANIES INC 17,773$36,0790.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 52,167$105,8990.00%
Legal & General Group Plc 12,308$24,9850.00%
STATE STREET CORP 2,161,401$4,387,6440.00%
PRICE T ROWE ASSOCIATES INC /MD/ 26,735$550.00%
NEW YORK STATE COMMON RETIREMENT FUND 45,246$920.00%
NISA INVESTMENT ADVISORS, LLC 3,750$7,6130.00%
External links

This page lists ARBUTUS BIOPHARMA CORP's shareholders in Q3 2023. To view ARBUTUS BIOPHARMA CORP's shareholder history, click here.